Bayer Launches Centafore Imaging Core Lab to Support Imaging for Clinical Trials and Software as a Medical Device Development
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced the launch of its Imaging Core Lab Services under the brand name Centafore. With over 25 years of experience supporting more than 200 clinical trials at Bayer and its arm's length companies globally, Centafore is now positioned as a distinct Imaging solution provider, offering tailored services for external customers to support their clinical trials and Software as a Medical Device (SaMD) development across diverse therapeutic areas and development phases. Attendees of the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO) will get the chance to learn more about the Centafore team, technology and its services in Chicago from May 30 till June 3 (Booth #24152).
Centafore provides technology and services for image management, processing, and interpretation, empowering study sponsors with expert project management and facilitating advanced analyses of imaging data. Its extensive network includes experienced imaging professionals like board-certified radiologists, enabling customers to effectively manage studies across more than 50 countries.
'Centafore represents a significant leap forward in our commitment to enhancing the landscape of clinical trial imaging and advancing the development of new medicines and healthcare solutions,' said Nelson Ambrogio, President of Radiology at Bayer. 'By leveraging our extensive experience and expertise, we are dedicated to providing our customers with high quality imaging services that meet their specific needs in clinical research. Through Centafore, we aim to enhance the reliability of trial outcomes and support informed decision-making in the development of investigational medicines, ultimately benefiting patients and improving their quality of care.'
Centafore's services support a wide range of therapeutic areas, including oncology, cardiovascular, CNS, dermatology, women's health, pediatrics, and digital health. It aims to help pharmaceutical, biotech, medical device and digital health companies with early research through Phase IV trials and SaMD development, and adherence to regulatory and data privacy compliance standards.
As part of Bayer's ongoing efforts to support global healthcare startups, the Imaging Core Lab Services of Bayer have been first presented at ECR 2024. Centafore is already collaborating with organizations such as OBIO® and Luxsonic Technologies to leverage clinical imaging as a critical tool for improving decision-making in clinical trials and software as a medical device (SaMD) development.
About Centafore
Centafore is an Imaging Contract Research Organization (iCRO) that supports early research through phase IV trials and Software as a Medical Device (SaMD) development for pharma, biotech, medical device and digital health companies.
For over 25 years, it has been the primary, trusted iCRO for Bayer, playing a vital role in advancing the company's drug pipeline – and now, extended its expertise to external customers under the brand name Centafore, delivering high-quality support for imaging studies and research initiatives across the industry.
About Bayer in Radiology
Building on a century of expertise, Bayer is committed to innovative products and high-quality services in diagnostic imaging to enhance patient care. Its leading radiology portfolio features contrast agents and devices for precise administration across modalities including computed tomography (CT), X-ray and magnetic resonance imaging (MRI), and positron emission tomography (PET). Bayer's comprehensive offerings also include informatics solutions, a curated marketplace with digital and artificial intelligence (AI) enabled applications. In 2024, Bayer's radiology products generated €2.1 billion in global sales. Committed to research and innovation, Bayer continues to advance medical imaging with the ultimate goal to improve patient outcomes.
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, 'Health for all, Hunger for none,' the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros. R&D expenses amounted to 6.2 billion euros. For more information, go to www.bayer.com.
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Lineage Announces Pricing of $500 million of Senior Notes due 2030
NOVI, Mich., June 10, 2025--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE) (the "Company"), today announced that Lineage OP, LP (the "Operating Partnership"), a direct subsidiary of the Company, priced an offering of $500 million aggregate principal amount of 5.250% Senior Notes due 2030 (the "Notes") at a price of 98.991% of the principal amount. The Notes will be senior unsecured obligations of the Operating Partnership and will be fully and unconditionally guaranteed by the Company, Lineage Logistics Holdings, LLC and each other subsidiary of the Company (other than the Operating Partnership and certain excluded subsidiaries) that guarantees or is otherwise obligated in respect of the Company's revolving credit and term loan agreement. Interest on the Notes will accrue at a rate of 5.250% per annum and be payable semi-annually on January 15 and July 15 of each year. The Notes will mature on July 15, 2030. Closing of the offering is expected to occur on June 17, 2025, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the Notes to repay amounts outstanding from time to time under its revolving credit facility and for other general corporate and working capital purposes. The Notes have not been and will not be registered under the Securities Act of 1933, as amended (the "Securities Act"), or any state securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the Securities Act. The Notes will be offered only to "qualified institutional buyers" under Rule 144A of the Securities Act or, outside the United States, to persons other than "U.S. persons" in compliance with Regulation S under the Securities Act. This communication is not an offer to sell or a solicitation of an offer to buy securities of Linage, Inc. or its subsidiaries, nor shall it constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. There can be no assurances that the offering of the Notes will be completed as described herein or at all. Safe Harbor Statement This press release contains forward-looking statements which are based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially, including statements related to the timing and consummation of the offering of the Notes and the expected use of the net proceeds. Forward-looking statements can generally be identified by the use of words such as words "estimate," "anticipate," "expect," "believe," "intend," "may," "will," "could," "should," "would," "seek," "position," "support," "drive," "enable," "optimistic," "target," "opportunity," "approximately" or "plan," or the negative of these words and phrases or similar words or phrases that are predictions of or indicate future events or trends and that do not relate solely to historical matters are intended to identify forward-looking statements. You can also identify forward-looking statements by discussions of strategy, plans or intentions of management. The Company can provide no assurances that it will be able to complete the offering on the anticipated terms, or at all. For a further list and description of such risks and uncertainties, see the Company's reports and other filings with the U.S. Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2024. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. View source version on Contacts Investor Relations ContactEvan BarbosaVP, Investor Relationsir@ Media Contact Megan HendricksenVP, Global Marketing & Communicationspr@
Business Wire
an hour ago
- Business Wire
Lineage Announces Pricing of $500 million of Senior Notes due 2030
NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE) (the 'Company'), today announced that Lineage OP, LP (the 'Operating Partnership'), a direct subsidiary of the Company, priced an offering of $500 million aggregate principal amount of 5.250% Senior Notes due 2030 (the 'Notes') at a price of 98.991% of the principal amount. The Notes will be senior unsecured obligations of the Operating Partnership and will be fully and unconditionally guaranteed by the Company, Lineage Logistics Holdings, LLC and each other subsidiary of the Company (other than the Operating Partnership and certain excluded subsidiaries) that guarantees or is otherwise obligated in respect of the Company's revolving credit and term loan agreement. Interest on the Notes will accrue at a rate of 5.250% per annum and be payable semi-annually on January 15 and July 15 of each year. The Notes will mature on July 15, 2030. Closing of the offering is expected to occur on June 17, 2025, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the Notes to repay amounts outstanding from time to time under its revolving credit facility and for other general corporate and working capital purposes. The Notes have not been and will not be registered under the Securities Act of 1933, as amended (the 'Securities Act'), or any state securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the Securities Act. The Notes will be offered only to 'qualified institutional buyers' under Rule 144A of the Securities Act or, outside the United States, to persons other than 'U.S. persons' in compliance with Regulation S under the Securities Act. This communication is not an offer to sell or a solicitation of an offer to buy securities of Linage, Inc. or its subsidiaries, nor shall it constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. There can be no assurances that the offering of the Notes will be completed as described herein or at all. Safe Harbor Statement This press release contains forward-looking statements which are based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially, including statements related to the timing and consummation of the offering of the Notes and the expected use of the net proceeds. Forward-looking statements can generally be identified by the use of words such as words 'estimate,' 'anticipate,' 'expect,' 'believe,' 'intend,' 'may,' 'will,' 'could,' 'should,' 'would,' 'seek,' 'position,' 'support,' 'drive,' 'enable,' 'optimistic,' 'target,' 'opportunity,' 'approximately' or 'plan,' or the negative of these words and phrases or similar words or phrases that are predictions of or indicate future events or trends and that do not relate solely to historical matters are intended to identify forward-looking statements. You can also identify forward-looking statements by discussions of strategy, plans or intentions of management. The Company can provide no assurances that it will be able to complete the offering on the anticipated terms, or at all. For a further list and description of such risks and uncertainties, see the Company's reports and other filings with the U.S. Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2024. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Yahoo
an hour ago
- Yahoo
Wolters Kluwer executive delivers keynote on the future of integrated tech stacks and agentic AI at AICPA Engage 2025
Cathy Rowe explores how unified tech stacks and agentic AI are transforming audits, tax workflows, and firm-wide decision-making. MINNEAPOLIS, June 10, 2025--(BUSINESS WIRE)--Wolters Kluwer Tax and Accounting (TAA) executive, Cathy Rowe, Senior Vice President and Segment Leader, U.S. Professional Market, delivered a compelling keynote address today at AICPA Engage 2025, held at the Aria Resort and Casino in Las Vegas. Her remarks focused on the accelerating pace of technological change and how integrated tech stacks and agentic AI are reshaping the accounting profession for audit and tax professionals. In her keynote, Rowe emphasized that the rate of technological change is now faster than ever, urging firms to embrace both sustaining and disruptive innovation. She shared insights from Wolters Kluwer's "Future Ready Accountant" study, which found that 77% of firms experienced growth last year, yet 40% cited keeping up with new technology as their top challenge. Rowe highlighted that firms using fully integrated solutions reported revenue increases of 10% or more, underscoring the ROI of strategic tech investments. She outlined four key pillars for leveraging AI in modern firms: Data-Driven Firm Management – Using AI to generate real-time insights and automate reporting. Increased Efficiencies and Capacity – Streamlining workflows and optimizing staff allocation. Proactive Risk Management – Monitoring tax and audit data to identify and mitigate risks. Enhanced Client Service – Shifting from compliance to advisory roles through AI-driven insights and automation. A central theme of Rowe's address was the emergence of agentic AI—a transformative evolution from traditional automation to intelligent agents that act autonomously with human oversight. She explained how agentic AI spans four key categories: Taskers, Automators, Collaborators, and Orchestrators. These agents can classify documents, manage workflows, guide professionals through complex tasks, and even orchestrate entire audit or tax preparation processes. Crucially, this next-generation AI is made possible through open integration platforms, enabling firms of all sizes to benefit from seamless automation, data interoperability, and intelligent decision-making. "Agentic AI is not just a buzzword—it's a strategic enabler," Rowe stated. "It empowers professionals to work at the top of their credentials, enhances client service, and creates competitive advantage. With open integration APIs, firms can build intelligent, responsive systems that adapt in real time." Wolters Kluwer is actively advancing the integration of agentic AI across its suite of tax and accounting solutions as part of its long-term innovation strategy centered on firm intelligence. Building on more than a decade of AI investment, these enhancements will empower professionals to automate complex workflows, enhance decision-making, and deliver greater value to clients. Customers can expect to begin experiencing these next-generation capabilities in the near future, reinforcing Wolters Kluwer's commitment to helping firms stay future-ready. Rowe concluded by encouraging firms to assess their current workflows, evaluate integration opportunities, and invest in talent and change management to become truly future-ready. Professionals interested in learning how Wolters Kluwer can help them prepare for the future are encouraged to contact their sales representative. Interview Opportunity Media interested in scheduling an interview with Cathy Rowe may reach out to Shannon Wherry, Associate Director, External Communications at About Wolters Kluwer Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services. Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. For more information, visit and follow us on LinkedIn, Facebook, YouTube and Instagram. View source version on Contacts Media Contacts Shannon WherryAssociate Director, External CommunicationsWolters Kluwer Tax & AccountingOffice: +1
